Seal the Tract: Microfibrillar Collagen After Liver Biopsy
From Wysdom Radio™ · 17:02
Show by Wysdom
This episode breaks down the first large study of microfibrillar collagen tract embolization (MCTE) in percutaneous liver biopsy (Arasteh et al., JVIR 2026), a single-center review of routine Avitene tract embolization after ultrasound-guided, nontargeted native and transplant liver biopsy. Following, there is an expert commentary by Dr. Ken Zurcher, the study's senior author and an interventional radiologist with Vascular & Interventional Partners at Banner University Medical Center Phoenix.The Premise: Bleeding remains the most important complication of percutaneous liver biopsy, with major bleeding reported in 0.4–1.4% of cases. Gelatin sponge tract embolization lowers that risk, but evidence for microfibrillar collagen (Avitene) in routine liver biopsy was limited to one small transhepatic access series.The Study: A retrospective cohort at Banner University Medical Center Phoenix (August 2022 to July 2025) included 695 consecutive nontargeted native (73.7%) or transplant (26.3%) liver biopsies, all with a 17-gauge/18-gauge coaxial system and routine MCTE. Targeted lesion biopsies were excluded.The Technique: 0.5 g of microfibrillar collagen is mixed with 3 mL of saline into a paste, loaded into a 1-mL Medallion syringe, and injected through the 17-gauge introducer under ultrasound while the needle is withdrawn, stopping short of the liver capsule to limit pain.Outcomes: Major bleeding occurred in 1 of 695 biopsies (0.14%), and minor bleeding in 1 of 695 (0.14%). The mean number of passes was 2.41. Seventeen patients (2.4%) were readmitted within 30 days, none for biopsy-related events, and 31 (4.5%) returned to the ED with biopsy-attributed symptoms such as pain.Caveats: The study was retrospective and single-center, with no contemporaneous control group, so comparisons are to historical benchmarks. Hemoglobin and imaging were obtained only when symptoms developed, so minor bleeds may be undercounted, and microfibrillar collagen costs more than gelatin sponge.Expert Take: Dr. Zurcher explains why targeted biopsies were excluded to keep the data clean and shares his technique: inject until you see the Avitene on ultrasound, retract in a smooth motion while continuously injecting, and make a definite point of stopping before the capsule. He also covers future comparisons against gelatin sponge, the cost trade-off, and upcoming work using Avitene to close kidney biopsy tracts and transhepatic and transsplenic portal access sheaths.Tune in to learn how routine microfibrillar collagen tract embolization can make liver biopsy safer.This podcast is generated using an AI model that has been trained in the context of endovascular surgery and interventional radiology in addition context of the article cited below. The content was reviewed and edited by multiple healthcare professionals in the field. Arasteh A, Kim A, Sprout G, et al. Microfibrillar collagen tract embolization in percutaneous liver biopsy: a single-center experience. J Vasc Interv Radiol. 2026;37(11):109045. doi:10.1016/j.jvir.2026.109045
More episodes of Wysdom Radio™
More episodes
- Doubling Survival in Intermediate-Stage HCC: Y90 vs DEB-TACE (TRACE)
- Communicating After Complications: The Untaught Procedure
- Early TIPS in Acute Variceal Bleeding
- Ablate (RFA) and Stabilize (Cement): OsteoCool RFA for Painful Bone Metastases, with Dr. Jason Levy (OPuS One)
- EMMY at 10 Years: Two-Thirds Avoid Hysterectomy
- Beyond the Drug: What Makes TACE Work?
- Infra-popliteal Bioresorbable Stents: The NEJM LIFE-BTK Trial
- Fractured IVC Filter Fragments: The Penn Perspective
- The Golden Era of PE Trials: PRAGUE-26
- CREST-2 Trial Explained (Carotid Stenosis Treatment)
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.